Publication:
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients.

dc.contributor.authorTrujillo-Rodriguez, Maria
dc.contributor.authorMuñoz-Muela, Esperanza
dc.contributor.authorSerna-Gallego, Ana
dc.contributor.authorPraena-Fernandez, Juan Manuel
dc.contributor.authorPerez-Gomez, Alberto
dc.contributor.authorGasca-Capote, Carmen
dc.contributor.authorVitalle, Joana
dc.contributor.authorPeraire, Joaquim
dc.contributor.authorPalacios-Baena, Zaira R
dc.contributor.authorCabrera, Jorge Julio
dc.contributor.authorRuiz-Mateos, Ezequiel
dc.contributor.authorPoveda, Eva
dc.contributor.authorLopez-Cortes, Luis Eduardo
dc.contributor.authorRull, Anna
dc.contributor.authorGutierrez-Valencia, Alicia
dc.contributor.authorLopez-Cortes, Luis Fernando
dc.contributor.funderConsejeria de Salud y Familia
dc.contributor.funderConsejeria de Transformacion Economica, Industria, Conocimiento y Universidades
dc.contributor.funderInstituto de Salud Carlos III Spanish Government
dc.contributor.funderCentro de Investigacion Biomedica en Red de Enfermedades Infecciosas-ISCIII Madrid, Spain
dc.date.accessioned2023-05-03T13:36:46Z
dc.date.available2023-05-03T13:36:46Z
dc.date.issued2022-07-14
dc.description.abstractThe SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its severity in a high percentage of cases. Having tools to predict which patients can be safely early discharged would help to improve this situation. Patients confirmed as SARS-CoV-2 infection from four Spanish hospitals. Clinical, demographic, laboratory data and plasma samples were collected at admission. The patients were classified into mild and severe/critical groups according to 4-point ordinal categories based on oxygen therapy requirements. Logistic regression models were performed in mild patients with only clinical and routine laboratory parameters and adding plasma pro-inflammatory cytokine levels to predict both early discharge and worsening. 333 patients were included. At admission, 307 patients were classified as mild patients. Age, oxygen saturation, Lactate Dehydrogenase, D-dimers, neutrophil-lymphocyte ratio (NLR), and oral corticosteroids treatment were predictors of early discharge (area under curve (AUC), 0.786; sensitivity (SE) 68.5%; specificity (S), 74.5%; positive predictive value (PPV), 74.4%; and negative predictive value (NPV), 68.9%). When cytokines were included, lower interferon-γ-inducible protein 10 and higher Interleukin 1 beta levels were associated with early discharge (AUC, 0.819; SE, 91.7%; S, 56.6%; PPV, 69.3%; and NPV, 86.5%). The model to predict worsening included male sex, oxygen saturation, no corticosteroids treatment, C-reactive protein and Nod-like receptor as independent factors (AUC, 0.903; SE, 97.1%; S, 68.8%; PPV, 30.4%; and NPV, 99.4%). The model was slightly improved by including the determinations of interleukine-8, Macrophage inflammatory protein-1 beta and soluble IL-2Rα (CD25) (AUC, 0.952; SE, 97.1%; S, 98.1%; PPV, 82.7%; and NPV, 99.6%). Clinical and routine laboratory data at admission strongly predict non-worsening during the first two weeks; therefore, these variables could help identify those patients who do not need a long hospitalization and improve hospital overcrowding. Determination of pro-inflammatory cytokines moderately improves these predictive capacities.
dc.description.versionSi
dc.identifier.citationTrujillo-Rodriguez M, Muñoz-Muela E, Serna-Gallego A, Praena-Fernández JM, Pérez-Gómez A, Gasca-Capote C, et al. Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients. PLoS One. 2022 Jul 14;17(7):1-15.
dc.identifier.doi10.1371/journal.pone.0269875
dc.identifier.essn1932-6203
dc.identifier.pmcPMC9282584
dc.identifier.pmid35834501
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282584/pdf
dc.identifier.unpaywallURLhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0269875&type=printable
dc.identifier.urihttp://hdl.handle.net/10668/20431
dc.issue.number7
dc.journal.titlePloS one
dc.journal.titleabbreviationPLoS One
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen Macarena
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.page.number15
dc.provenanceRealizada la curación de contenido 03/04/2025
dc.publisherPublic Library of Science
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.relation.projectIDCOVID-00052020
dc.relation.projectIDRH-0037-2020
dc.relation.projectIDPY20/01276
dc.relation.projectIDCP19/00159
dc.relation.projectIDCP19/00146
dc.relation.projectIDFI19/00304
dc.relation.projectIDFI19/00083
dc.relation.projectIDCOV20/00698
dc.relation.publisherversionhttps://dx.plos.org/10.1371/journal.pone.0269875
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCOVID-19
dc.subjectHumans
dc.subjectPatient Discharge
dc.subject.decsPacientes
dc.subject.decsLaboratorios
dc.subject.decsCitocinas
dc.subject.decsHospitales
dc.subject.decsCorticoesteroides
dc.subject.decsSaturación de oxígeno
dc.subject.decsPandemias
dc.subject.decsNeutrófilos
dc.subject.decsInterferones
dc.subject.decsInterleucina-1beta
dc.subject.decsLinfocitos
dc.subject.meshBiomarkers
dc.subject.meshCytokines
dc.subject.meshMale
dc.subject.meshSARS-CoV-2
dc.titleClinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number17
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 3 of 3
Loading...
Thumbnail Image
Name:
PMC9282584.pdf
Size:
1.43 MB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
Trujillo-Rodriguez_ClinicalLaboratory_Correción.pdf
Size:
223.74 KB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
Trujillo-Rodriguez_ClinicalLaboratory_MaterialSuplementario.zip
Size:
1.37 MB
Format: